Potassium Balance in Dialysis Patients

Seminars in Dialysis

Volumn 26, Issue 5, 2013, Pages 597-603

  Sanghavi, Sarah ^a   Whiting, Susan ^b   Uribarri, Jaime ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM;

ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; ELECTROLYTE BALANCE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; PHYSIOLOGY; RENAL REPLACEMENT THERAPY;

HUMANS; HYPERKALEMIA; HYPOKALEMIA; KIDNEY FAILURE, CHRONIC; POTASSIUM; RENAL DIALYSIS; WATER-ELECTROLYTE BALANCE;

EID: 84884698656     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12123     Document Type: Article

References (59)

1. Ahmed J, Weisberg LS: Hyperkalemia in dialysis. Semin Dial 14(5):348-356, 2001
2. Mattu A, Brady WJ, Robinson DA: Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med 18:721, 2000
3. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-S119, 1998
4. Pun P, Ruediger W, Lehrich E, Honeycutt E, Herzog C, Middleton J: Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 79:218-227, 2011
5. Glassock R, Pecoits-Filho R: Left ventricular mass in chronic kidney disease and ESRD. CJASN 4:S79-S91, 2009
6. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister C, Greenland S, Kopple J, Kalantar-Zadeh K: Serum and dialysate potassium concentrations and survival in hemodialysis patients. CJASN 2:999-1007, 2007
7. Lin CH, Tu YF, Chiang WC, Wu SY, Chang YH, Chi CH: Electrolyte abnormalities and laboratory findings in patients with out-of-hospital cardiac arrest who have kidney disease. Am J Emerg Med 31(3):487-493, 2013
8. Foley RN, Gilbertson DT, Murray T, Collins AJ: Long interdialytic interval and mortality among patients receiving hemodialysis. N Engl J Med 365(12):1099-1107, 2011
9. Zhang H, Schaubel DE, Kalbfleisch JD, Bragg-Gresham JL, Robinson BM, Pisoni RL, Canaud B, Jadoul M, Akiba T, Saito A, Port FK, Saran R: Dialysis outcomes and analysis of practice patterns suggests the dialysis schedule affects day-of-week mortality. Kidney Int 81(11):1108-1115, 2012
10. Saran R, Bragg-Gresham J, Rayner HC, Goodkin D, Keen M, VanDijk P, Kurokawa K, Piera L, Saito A, Fukuhara S, Young E, Held P, Port FK: Nonadherence in hemodialysis: Associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int 64:254-262, 2003
11. Torlén K, Kalantar-Zadeh K, Molnar MZ, Vashistha T, Mehrotra R: Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort. CJASN 7(8):1272-1284, 2012
12. Sandle GI, Gaiger E, Tapster S, Goodship TH: Evidence for large intestinal control of potassium homoeostasis in uraemic patients undergoing long term dialysis. Clin Sci 73:247-252, 1987
13. Zanger R: Hyponatremia and hypokalemia in patients on peritoneal dialysis. Semin Dial 23(6):575-580, 2010
14. Blumberg A, Roser HW, Zehnder C, Muller-Brand J: Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium. Nephrol Dial Transplant 12:1629-1634, 1997
15. Zehnder C, Gutzwiller JP, Huber A, Schindler C, Schneditz D: Low-potassium and glucose-free dialysis maintains urea but enhances potassium removal. Nephrol Dial Transplant 16:78-84, 2001
16. Rachoin JS, Weisberg LS: How should dialysis fluid be individualized for the chronic hemodialysis patient? Potassium Semin Dial 21:223-225, 2008
17. Mathialahan T, Maclennan KA, Sandle LN, Verbeke C, Sandle GI: Enhanced large intestinal potassium permeability in end-stage renal disease. J Pathol 206:46-51, 2005
18. Hayslett JP, Myketey N, Binder HJ, Aronson PS: Mechanism of increased potassium secretion in potassium loading and sodium deprivation. Am J Physiol 239:F378-F382, 1980
19. Yasuda G, Shibata K, Takizawa T, Ikeda Y, Tokita Y, Umemura A, Tochikubo O: Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients. Am J Kidney Dis 39(6):1292-1299, 2002
20. Institute of Medicine: Dietary Reference Intakes: Sodium, Chloride, Potassium and Sulphate. The National Academies Press: National Academy Press, 2005
21. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 336:1117-1124, 1997
22. Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 277:1624-1632, 1997
23. Adrogué HJ, Madias NE: Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 356(19):1966-1978, 2007
24. Lacey K, Nelms MN: Diseases of the Renal System. In: Nelms MN, Sucher KP, Lacey K, Roth SL (eds). Nutrition Therapy & Pathophysiology, 2nd ed. Belmont CA: Wadsworth Centgage Learning, 2007
25. National Kidney Foundation: A to Z Health Guide (Potassium in your diet). Available at http://www.kidney.org/atoz/content/potassium.cfm. Accessed March 8, 2013
26. Curtis CJ, Niederman SA, Kansagra SM: Availability of potassium on the Nutrition Facts panel of US packaged foods. JAMA Intern Med 25:1-2, 2013
27. Sherman RA, Mehta O: Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. Clin J Am Soc Nephrol 4(8):1370-1373, 2009
28. Sherman RA, Mehta O: Potassium in food additives: something else to consider. J Ren Nutr 19(6):441-442, 2009
29. Burrowes JD, Ramer NJ: Changes in potassium content of different potato varieties after cooking. J Ren Nutr 18(6):530-534, 2008
30. Morales Lopez C, Burrowes JD, Gizis F, Brommage D: Dietary adherence in Hispanic patients receiving hemodialysis. J Ren Nutr 17:138-147, 2007
31. Sherman RA, Hwang ER, Bernholc AS, Eisinger RP: Variability in potassium removal by hemodialysis. Am J Nephrol 6:284-288, 1986
32. Khalil A, Frazier S, Lennie T, Swaya P: Depressive symptoms and dietary adherence in patients with end-stage renal disease. J Ren Care 37:30-39, 2011
33. Turban S, Thompson CB, Parekh RS, Appell LJ: Effects of sodium intake and diet on racial differences in urinary potassium excretion: results from the Dietary Approaches to Stop Hypertension (DASH)-Sodium trial. Am J Kidney Dis 61(1):88-95, 2013
34. Akman B, Uyar M, Afsar B, Sezer S, Ozdemir F: Adherence, depression and quality of life in patients on a renal transplantation waiting list. Trans Int 5:1-6, 2007
35. Sagduyu A, Senturk V, Sezer S, Emiroglu R, Ozel S: Psychiatric problems, quality of life, and compliance in patients treated with hemodialysis and renal transplantation. Turkish J Psychiatr 17:1-10, 2006
36. Ford JC, Pople JF, Hunt AE, Gerald B: The effect of diet education on the laboratory values and knowledge of hemodialysis patients with hyperphosphatemia. J Ren Nutr 14(1):36-44, 2004
37. Hörl MP, Hörl WH: Drug therapy for hypertension in hemodialysis patients. Semin Dial 17:288, 2004
38. Vilar E, Farrington K: Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24(5):487-494, 2011
39. Cannella G, Paoletti E, Delfino R, Peloso G, Rolla D, Molinari S: Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am J Kidney Dis 30:659-664, 1997
40. Yang LY, Ge X, Wang YL, Ma KL, Liu H, Zhang XL, Liu BC: Angiotensin receptor blockers reduce left ventricular hypertrophy in dialysis patients: a meta-analysis. Am J Med Sci 345(1):1-9, 2013
41. Messerli FH, Nunez BD, Nunez MM, Garavaglia G, Schmieder E: Hypertension and sudden death. Disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias. Arch Intern Med 149:1263, 1989
42. Okin PM, Devereux RB, Jern S, Kjeldsen S, Julius S, Nieminen M, Snapinn S, Harris K, Aurup P, Edelman J, Wedel H, Lindholm L, Dahlöf B: Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 292:2343, 2004
43. Pierdomenico SD, Lapenna D, Cuccurullo F: Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension. Am J Hypertens 21(4):464-470, 2008
44. Garthwaite E, Bhandari S: The effects of angiotensin converting enzyme inhibitors on potassium homeostasis in dialysis patients with and without residual renal function. Artif Organs 33(8):641-647, 2009
45. Cice G, Di Benedetto A, D'Isa S, D'Andrea A, Marcelli D, Gatti E, Calabrò R: Effects of telmisartan added to Angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial. J Am Coll Cardiol 56(21):1701-1708, 2010
46. Knoll GA, Sahgal A, Nair RC, Graham J, van Walraven C, Burns KD: Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. Am J Med 112:110-114, 2002
47. Turnamian SG, Binder HJ: Regulation of active sodium and potassium transport in the distal colon of the rat. Role of the aldosterone and glucocorticoid receptors. J Clin Invest 84(6):1924-1929, 1989
48. Hatch M, Freel RW, Vaziri ND: Losartan antagonism of angiotensin-II-induced potassium secretion across rat colon. Pflugers Arch 436(5):717-724, 1998
49. Phakdeekitcharoen B, Leelasa-Nguan P: Effects of an ACE-inhibitor or angiotensin receptor blocker on potassium in CAPD patients. Am J Kidney Dis 44:738-746, 2004
50. Garg J, Bakris GL: Angiotensin converting enzyme inhibitors or angiotensin receptor blockers in nephropathy from type 2 diabetes. Curr Hypertens Rep 4(3):185-190, 2002
51. Zannad F, McMurray J, Krum H, van Veldhuisen D, Swedberg K, Shi H, Vincent J, Pocock S, Pitt B; for the EMPHASIS-HF Study Group: Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11-21, 2011
52. Taheri S, Mortazavi M, Shahidi S, Pourmoghadas A, Garakyaraghi M, Seirafian S, Eshaghian A, Ghassami M: Spironolactone in chronic hemodialysis patients improves cardiac function. Saudi J Kidney Dis Transpl 20(3):392-397, 2009
53. Singhal PC, Desroches L, Mattana J, Abramovici M, Wagner JD, Maesaka JK: Mineralocorticoid therapy lowers serum potassium in patients with end-stage renal disease. Am J Nephrol 13(2):138-141, 1993
54. Kaisar MO, Wiggins KJ, Sturtevant JM, Hawley C, Campbell S, Isbel N, Mudge D, Bofinger A, Petrie J, Johnson D: A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients. Am J Kidney Dis 47:809-814, 2006
55. Chaaban A, Abouchacra S, Gebran N, Abayechi F, Hussain Q, Al Nuaimi N, Hassan ME: Potassium binders in hemodialysis patients: a friend or foe? Ren Fail 35(2):185-188, 2013
56. Gifford JD, Rutsky EA, Kirk KA, McDaniel HG: Control of serum potassium during fasting in patients with ESRD. Kidney Int 35:90-94, 1989
57. Blumberg A, Weidmann P, Weidmann P, Shaw S, Gnädinger M: Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 85:507-512, 1988
58. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS; FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363(24):2287-2300, 2010
59. de Bie MK, Lekkerkerker JC, van Dam B, Gaasbeek A, van Buren M, Putter H, van Erven L, Bax JJ, Schalij MJ, Rabelink TJ, Jukema JW: Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial-a prospective pilot study. Curr Med Res Opin 24(8):2151-2157, 2008